PEPTONIC MEDICAL (28L) — Financial Flexibility Index
PEPTONIC MEDICAL (28L) has a Financial Flexibility Index of -0.25x as of September 2025. Free cash flow of €-7.43 Million (operating CF €-7.43 Million minus capex €0.00) represents 0% of total liabilities (€29.18 Million). Also explore how fast is PEPTONIC MEDICAL growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PEPTONIC MEDICAL Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for PEPTONIC MEDICAL across 4 annual periods. See PEPTONIC MEDICAL (28L) net asset quality to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for PEPTONIC MEDICAL (2021–2024)
Year-by-year free cash flow to debt coverage for PEPTONIC MEDICAL. For the full company profile including market capitalisation, see 28L market cap overview.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.65x | €-36.35 Million | €-37.55 Million | €22.01 Million | ▼ -62.8% |
| 2023 | -1.01x | €-31.88 Million | €-33.81 Million | €31.41 Million | ▼ 0.0% |
| 2022 | -1.01x | €-39.23 Million | €-40.22 Million | €38.66 Million | ▲ +11.4% |
| 2021 | -1.15x | €-36.06 Million | €-40.34 Million | €31.48 Million | — |